ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 414 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,257 | -80.8% | 14,649 | -81.5% | 0.01% | -82.0% |
| Q1 2024 | $6,541 | +907.9% | 79,213 | +719.8% | 0.05% | +733.3% |
| Q3 2023 | $649 | -79.0% | 9,663 | -83.1% | 0.01% | -76.9% |
| Q1 2023 | $3,090 | -98.5% | 57,117 | +1495.9% | 0.03% | +1200.0% |
| Q2 2022 | $201,000 | -46.7% | 3,579 | -32.5% | 0.00% | -60.0% |
| Q1 2022 | $377,000 | -79.0% | 5,299 | -80.7% | 0.01% | -73.7% |
| Q4 2021 | $1,792,000 | -84.2% | 27,456 | -81.9% | 0.02% | -87.6% |
| Q3 2021 | $11,356,000 | +198.4% | 151,297 | +210.2% | 0.15% | +264.3% |
| Q2 2021 | $3,806,000 | +185.7% | 48,776 | +202.9% | 0.04% | +223.1% |
| Q4 2020 | $1,332,000 | +156.2% | 16,104 | +101.3% | 0.01% | +30.0% |
| Q3 2020 | $520,000 | -78.4% | 7,999 | -79.4% | 0.01% | -83.9% |
| Q2 2020 | $2,403,000 | +128.0% | 38,802 | +155.0% | 0.06% | +210.0% |
| Q4 2019 | $1,054,000 | – | 15,215 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
| Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
| MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
| Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
| REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
| Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
| Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
| GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
| BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |